• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体抑制剂CL-387785抑制肺腺癌进展。

EGFR Inhibitor CL-387785 Suppresses the Progression of Lung Adenocarcinoma.

作者信息

Cai Yong, Sheng Zhaoying, Dong Zhiyi, Wang Jiying

机构信息

Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.

Department of Traditional Chinese Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.

出版信息

Curr Mol Pharmacol. 2023;16(2):211-216. doi: 10.2174/1874467215666220329212300.

DOI:10.2174/1874467215666220329212300
PMID:35352671
Abstract

OBJECTIVE

This study aimed to explore the influence of the irreversible EGFR inhibitor CL-387785 on invasion, metastasis, and radiation sensitization of non-small cell lung cancer cells.

METHODS

The proliferation inhibitory rate at different time points was detected by MTT assay. The apoptosis of H1975 cells treated with CL-387785 was detected using flow cytometry. The invasion and migration of H1975 cells treated with CL-387785 were determined by Transwell assay and wound healing assay. The survival fraction (SF) of H1975 cells cultured with CL- 387785 under X-ray (0, 2, 4, 6, 8, and 10 Gy) was detected by cloning formation experiment, and the sensitization ratio (SER) was calculated by clicking the multi-target model to fit the cell survival curve.

RESULTS

CL-387785 restrained H1975 cell proliferation in a concentration- and time-dependent manner. CL-387785 promoted H1975 cell apoptosis and reduced cell migration distance and the number of transmembrane cells. The SF treated by different concentrations of CL-387785 (10, 25, 50, and 100 nM) was all below 0 nM. The radiation SER of CL-387785 (10, 25, 50 and 100 nM) were 1.17, 1.39, 2.88, and 3.64, respectively.

CONCLUSION

The invasion and metastasis of H1975 cells were restrained by irreversible EGFR inhibitor CL-387785. CL-387785 also exhibited the effect of radiotherapy sensitization.

摘要

目的

本研究旨在探讨不可逆表皮生长因子受体(EGFR)抑制剂CL-387785对非小细胞肺癌细胞侵袭、转移及辐射增敏的影响。

方法

采用MTT法检测不同时间点的增殖抑制率。运用流式细胞术检测经CL-387785处理的H1975细胞的凋亡情况。通过Transwell实验和划痕实验测定经CL-387785处理的H1975细胞的侵袭和迁移能力。采用克隆形成实验检测在X射线(0、2、4、6、8和10 Gy)照射下经CL-387785培养的H1975细胞的存活分数(SF),并通过点击多靶点模型拟合细胞存活曲线计算增敏比(SER)。

结果

CL-387785以浓度和时间依赖性方式抑制H1975细胞增殖。CL-387785促进H1975细胞凋亡,减少细胞迁移距离和穿膜细胞数量。不同浓度(10、25、50和100 nM)的CL-387785处理后的SF均低于0 nM。CL-387785(10、25、50和100 nM)的辐射SER分别为1.17、1.39、2.88和3.64。

结论

不可逆EGFR抑制剂CL-387785抑制H1975细胞的侵袭和转移。CL-387785还具有放疗增敏作用。

相似文献

1
EGFR Inhibitor CL-387785 Suppresses the Progression of Lung Adenocarcinoma.表皮生长因子受体抑制剂CL-387785抑制肺腺癌进展。
Curr Mol Pharmacol. 2023;16(2):211-216. doi: 10.2174/1874467215666220329212300.
2
[The CK2 inhibitor quninalizarin enhances the anti-proliferative effect of icotinib on EGFR-TKIs-resistant cell lines and its underlying mechanisms].[CK2抑制剂醌茜素增强埃克替尼对表皮生长因子受体酪氨酸激酶抑制剂耐药细胞系的抗增殖作用及其潜在机制]
Zhonghua Zhong Liu Za Zhi. 2016 Feb;38(2):100-4. doi: 10.3760/cma.j.issn.0253-3766.2016.02.005.
3
Combination of BIBW2992 and ARQ 197 is effective against erlotinib-resistant human lung cancer cells with the EGFR T790M mutation.BIBW2992与ARQ 197联合使用对携带EGFR T790M突变的厄洛替尼耐药人肺癌细胞有效。
Oncol Rep. 2014 Jul;32(1):341-7. doi: 10.3892/or.2014.3178. Epub 2014 May 15.
4
Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.双重MET-EGFR联合抑制对T790M-EGFR介导的厄洛替尼耐药肺癌的作用
Br J Cancer. 2008 Sep 16;99(6):911-22. doi: 10.1038/sj.bjc.6604559.
5
The reverse effect of X-ray irradiation on acquired gefitinib resistance in non-small cell lung cancer cell line NCI-H1975 in vitro.X射线照射对非小细胞肺癌细胞系NCI-H1975体外获得性吉非替尼耐药的反向作用。
J Mol Histol. 2014 Dec;45(6):641-52. doi: 10.1007/s10735-014-9583-2. Epub 2014 Jul 10.
6
Melatonin sensitizes H1975 non-small-cell lung cancer cells harboring a T790M-targeted epidermal growth factor receptor mutation to the tyrosine kinase inhibitor gefitinib.褪黑素使携带靶向T790M的表皮生长因子受体突变的H1975非小细胞肺癌细胞对酪氨酸激酶抑制剂吉非替尼敏感。
Cell Physiol Biochem. 2014;34(3):865-72. doi: 10.1159/000366305. Epub 2014 Aug 21.
7
Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line.奥希替尼(AZD9291)耐药的非小细胞肺癌NCI-H1975/OSIR细胞系的特征分析
Oncotarget. 2016 Dec 6;7(49):81598-81610. doi: 10.18632/oncotarget.13150.
8
Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR-mutant non-small cell lung cancer.靶向 EMT 转录因子 Snail 可克服 EGFR 突变型非小细胞肺癌对奥希替尼的耐药性。
Thorac Cancer. 2021 Jun;12(11):1708-1715. doi: 10.1111/1759-7714.13906. Epub 2021 May 4.
9
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.针对非小细胞肺癌细胞中的表皮生长因子受体:RNA 干扰与酪氨酸激酶抑制剂或西妥昔单抗联合的效果。
BMC Med. 2012 Mar 21;10:28. doi: 10.1186/1741-7015-10-28.
10
[Effects of 17-DMAG on non-small cell lung cancer cell lines A549 and H1975
 being resistant to EGFR-TKI].17-二甲基氨基乙基氨基-17-去甲氧基格尔德霉素对耐表皮生长因子受体-酪氨酸激酶抑制剂的非小细胞肺癌细胞系A549和H1975的作用
Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):778-82. doi: 10.3779/j.issn.1009-3419.2014.11.02.

引用本文的文献

1
Comprehensive analysis of KRT18 as a novel prognostic biomarker and potential target in lung adenocarcinoma.KRT18作为肺腺癌新的预后生物标志物和潜在靶点的综合分析。
Clin Exp Med. 2025 Sep 1;25(1):312. doi: 10.1007/s10238-025-01855-0.
2
The cancer stem cells characteristics analysis of LGR5 + cells that influence lung cancer risk by using single cell RNA-seq analysis.利用单细胞RNA测序分析影响肺癌风险的LGR5+细胞的癌症干细胞特征
Sci Rep. 2025 May 8;15(1):16085. doi: 10.1038/s41598-025-00585-3.
3
Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma.
鉴定与NK/T细胞通讯相关的基因特征,以评估前列腺腺癌患者的肿瘤微环境和预后结果。
Front Immunol. 2025 Apr 16;16:1564784. doi: 10.3389/fimmu.2025.1564784. eCollection 2025.
4
Biomarkers associated with cell-in-cell structure in kidney renal clear cell carcinoma based on transcriptome sequencing.基于转录组测序的肾透明细胞癌中与细胞内细胞结构相关的生物标志物
PeerJ. 2025 Apr 16;13:e19246. doi: 10.7717/peerj.19246. eCollection 2025.
5
Exploration of telomere-related biomarkers for lung adenocarcinoma and targeted drug prediction.探索用于肺腺癌的端粒相关生物标志物及靶向药物预测。
Discov Oncol. 2025 Feb 10;16(1):148. doi: 10.1007/s12672-025-01847-2.
6
EGFR is a potential dual molecular target for cancer and Alzheimer's disease.表皮生长因子受体是癌症和阿尔茨海默病的潜在双重分子靶点。
Front Pharmacol. 2023 Aug 2;14:1238639. doi: 10.3389/fphar.2023.1238639. eCollection 2023.